Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Human Immunology
- Vol. 81 (6), 305-313
- https://doi.org/10.1016/j.humimm.2020.03.008
Abstract
No abstract availableFunding Information
- Ministry of Higher Education and Scientific Research of Tunisia
This publication has 82 references indexed in Scilit:
- Molecular pathology of endometrial carcinomaHistopathology, 2012
- HLA-E expression in cervical adenocarcinomas: association with improved long-term survivalJournal of Translational Medicine, 2012
- HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer PatientsThe Journal of Immunology, 2010
- Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Cellular and Molecular Life Sciences, 2010
- The Emerging Role of HLA-E-Restricted CD8+T Lymphocytes in the Adaptive Immune Response to Pathogens and TumorsJournal of Biomedicine and Biotechnology, 2010
- The prognostic role of classical and nonclassical MHC class I expression in endometrial cancerInternational Journal of Cancer, 2009
- Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancerJournal of Cellular and Molecular Medicine, 2009
- Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activationBlood, 2006
- Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cellsMolecular Immunology, 2006
- Linking Two Immuno-Suppressive Molecules: Indoleamine 2,3 Dioxygenase Can Modify HLA-G Cell-Surface Expression1Biology of Reproduction, 2005